Webinar: Filtration Technologies - An Overview

Watch Webinar Online
  • Homepage
  • Webinar - Virus Filtration Technologies: An Overview

Virus Filtration Technologies - An Overview

The commercial manufacturing of therapeutic antibodies or recombinant proteins requires robust and reliable processes that are economical and deliver high yields, while generating a product that is effective and safe for human use. One factor posing a threat to patient safety is the presence of viruses in the final product. Virus filtration is a widely used method for the removal of enveloped and non-enveloped viruses in the biopharmaceutical manufacturing process. It has been traditionally accepted as a robust method for virus clearance.

Sartorius will review the principles of virus technology and factors affecting virus safety. We will take a look at the Sartorius virus filters portfolio and consider the requirements to ensure the most reliable virus retention to meet stringent process conditions.


Register and Watch Now

Key Learning Objectives

  1. Virus filtration is one of the most used technologies for ensuring virus safety for the final product

  2. Sartorius virus filtration technology assures the most reliable virus retention even under challenging process conditions

  3. Sartorius provides the highest virus safety for your patient

Meet Our Experts

Juri Ceccarelli

Field Application Specialist Separation Technologies Italy | Spain | Portugal | Israel

Application Services, EMEA

Application Specialist in Separation Technologies, 15 years experienced in Sartorius in fields of filtration, purification and SU process . Previously 6 years of experience in aseptic filling manufacturing department.

Pablo Torres

Field Application Specialist Separation Technologies Spain | Portugal | Italy | Israel

Application Services, EMEA

Pablo Torres joined Sartorius Stedim Biotech in September 2019 as a Application Specialist for Separation Technologies. Pablo has over 4 years of experience in the biotechnology industry and specializes in downstream processing. Before joining Sartorius, Pablo had been working at mAbxience where he was involved in purification development activities. He holds a degree in Biotechnology  and two Master’s degrees in Drug Development and Pharmaceutical Marketing.

Complete Form To View Webinar Online